171 related articles for article (PubMed ID: 20146732)
1. Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis.
Mach P; Blecharz P; Basta P; Marianowski P; Skret-Magierlo J; Kojs Z; Grabiec M; Wicherek L
Am J Reprod Immunol; 2010 May; 63(5):387-95. PubMed ID: 20146732
[TBL] [Abstract][Full Text] [Related]
2. Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma.
Basta P; Mach P; Pitynski K; Bednarek W; Klimek M; Zietek J; Zajac K; Wicherek L
Neuro Endocrinol Lett; 2009 Mar; 30(1):91-8. PubMed ID: 19300397
[TBL] [Abstract][Full Text] [Related]
3. Alterations in RCAS1 serum concentration levels during the normal menstrual cycle and the lack of analogical changes in ovarian endometriosis.
Wicherek L
Am J Reprod Immunol; 2008 Jun; 59(6):535-44. PubMed ID: 18422812
[TBL] [Abstract][Full Text] [Related]
4. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
5. Quantification and identification of soluble HLA-G isoforms.
Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.
Schütt P; Schütt B; Switala M; Bauer S; Stamatis G; Opalka B; Eberhardt W; Schuler M; Horn PA; Rebmann V
Hum Immunol; 2010 May; 71(5):489-95. PubMed ID: 20156510
[TBL] [Abstract][Full Text] [Related]
7. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
[TBL] [Abstract][Full Text] [Related]
8. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Colombo BM; Contini P; Cagnati P; Pistorio A; Puppo F; Murdaca G
Allergy; 2008 Oct; 63(10):1335-8. PubMed ID: 18782112
[TBL] [Abstract][Full Text] [Related]
9. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
[TBL] [Abstract][Full Text] [Related]
10. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
[TBL] [Abstract][Full Text] [Related]
11. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
[TBL] [Abstract][Full Text] [Related]
12. The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot.
Matalliotakis IM; Athanassakis I; Goumenou AG; Neonaki MA; Koumantakis EE; Vassiliadis S; Koumantakis EE
Mediators Inflamm; 2001 Apr; 10(2):75-80. PubMed ID: 11405553
[TBL] [Abstract][Full Text] [Related]
13. Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies.
Sipak-Szmigiel O; Włodarski P; Ronin-Walknowska E; Niedzielski A; Karakiewicz B; Słuczanowska-Głąbowska S; Laszczyńska M; Malinowski W
J Ovarian Res; 2017 Apr; 10(1):25. PubMed ID: 28376925
[TBL] [Abstract][Full Text] [Related]
14. High serum follistatin levels in women with ovarian endometriosis.
Florio P; Reis FM; Torres PB; Calonaci F; Abrao MS; Nascimento LL; Franchini M; Cianferoni L; Petraglia F
Hum Reprod; 2009 Oct; 24(10):2600-6. PubMed ID: 19549703
[TBL] [Abstract][Full Text] [Related]
15. Alterations in RCAS1 serum concentration levels during menstrual cycle in patients with uterine leiomyoma and lack of analogical changes in adenomyosis.
Wicherek L
Gynecol Obstet Invest; 2009; 67(3):195-201. PubMed ID: 19122463
[TBL] [Abstract][Full Text] [Related]
16. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy.
Luque J; Torres MI; Aumente MD; Marín J; García-Jurado G; González R; Pascual D; Guerra N; López-Rubio F; Alvarez-López MR; Arizón JM; Peña J
Hum Immunol; 2006; 67(4-5):257-63. PubMed ID: 16720205
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
Chen HX; Lin A; Shen CJ; Zhen R; Chen BG; Zhang X; Cao FL; Zhang JG; Yan WH
Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
[TBL] [Abstract][Full Text] [Related]
18. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen-G, a ligand for the natural killer receptor KIR2DL4, is expressed by eutopic endometrium only in the menstrual phase.
Kawashima M; Maeda N; Adachi Y; Takeuchi T; Yamamoto Y; Izumiya C; Hayashi K; Furihata M; Udaka K; Fukaya T
Fertil Steril; 2009 Feb; 91(2):343-9. PubMed ID: 18314122
[TBL] [Abstract][Full Text] [Related]
20. Soluble HLA-G in rheumatoid arthritis.
Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
